On the public citation graph

Computation of the binding affinities of catechol‐O‐methyltransferase inhibitors: Multisubstate relative free energy calculations

0 signed · 115 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1521-3757(20011105)113:21<4164::aid-ange4164>3.0.co;2-vopenalex-snapshot
X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity
inferredcites →https://doi.org/10.1002/1521-3773(20011105)40:21<4040::aid-anie4040>3.0.co;2-copenalex-snapshot
X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity We thank F. Hoffmann–La Roche for generous support of this work. We are grateful to P. Malherbe for the cloning of COMT, P.…
inferredcites →https://doi.org/10.1002/anie.200200565openalex-snapshot
Binding Affinities of Host–Guest, Protein–Ligand, and Protein–Transition‐State Complexes
inferredcites →https://doi.org/10.1002/jcc.10369openalex-snapshot
Improving the efficiency and reliability of free energy perturbation calculations using overlap sampling methods
inferredcites →https://doi.org/10.1002/jcc.21450openalex-snapshot
Basic ingredients of free energy calculations: A review
inferredcites →https://doi.org/10.1002/pro.5560040405openalex-snapshot
Proline cis‐trans isomerization in staphylococcal nuclease: Multi‐substate free energy perturbation calculations
inferredcites →https://doi.org/10.1002/series2180openalex-snapshot
Methods of Biochemical Analysis
inferredcites →https://doi.org/10.1006/jmbi.1994.1430openalex-snapshot
Decomposition of the Free Energy of a System in Terms of Specific Interactions
inferredcites →https://doi.org/10.1006/jmbi.1996.0897openalex-snapshot
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
inferredcites →https://doi.org/10.1007/bf00123380openalex-snapshot
PLS modelling of structure?activity relationships of catechol O-methyltransferase inhibitors
inferredcites →https://doi.org/10.1007/bf00205107openalex-snapshot
Molecular-size corrections to the strength of the hydrophobic effect: a critical review
inferredcites →https://doi.org/10.1016/0009-2614(94)00397-1openalex-snapshot
Avoiding singularities and numerical instabilities in free energy calculations based on molecular simulations
inferredcites →https://doi.org/10.1016/0021-9991(76)90078-4openalex-snapshot
Efficient estimation of free energy differences from Monte Carlo data
inferredcites →https://doi.org/10.1016/0165-6147(89)90075-8openalex-snapshot
New selective COMT inhibitors: useful adjuncts for Parkinson's disease?
inferredcites →https://doi.org/10.1016/j.jmb.2008.04.040openalex-snapshot
Crystal Structures of Human 108V and 108M Catechol O-Methyltransferase
inferredcites →https://doi.org/10.1016/j.sbi.2005.03.001openalex-snapshot
Enhancing the accuracy, the efficiency and the scope of free energy simulations
inferredcites →https://doi.org/10.1016/s0006-3495(97)78756-3openalex-snapshot
The statistical-thermodynamic basis for computation of binding affinities: a critical review
inferredcites →https://doi.org/10.1016/s0021-9258(17)42348-9openalex-snapshot
Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo.
inferredcites →https://doi.org/10.1016/s0021-9258(18)64731-3openalex-snapshot
Enzymatic O-Methylation of Epinephrine and Other Catechols
inferredcites →https://doi.org/10.1016/s0022-2836(95)80037-9openalex-snapshot
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation
inferredcites →https://doi.org/10.1016/s0026-895x(24)12851-9openalex-snapshot
Molecular Mechanisms Controlling the Rate and Specificity of Catechol O-Methylation by Human Soluble Catechol O-Methyltransferase
inferredcites →https://doi.org/10.1016/s0031-6997(25)06681-5openalex-snapshot
Catechol-O-Methyl Transferase: Pharmacological Aspects and Physiological Role
inferredcites →https://doi.org/10.1016/s0163-7258(98)00032-1openalex-snapshot
New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s Disease
inferredcites →https://doi.org/10.1016/s1574-1400(07)03004-6openalex-snapshot
Chapter 4 Alchemical Free Energy Calculations: Ready for Prime Time?
inferredcites →https://doi.org/10.1021/ar00161a004openalex-snapshot
Free energy calculations: a breakthrough for modeling organic chemistry in solution
inferredcites →https://doi.org/10.1021/ar040257sopenalex-snapshot
Why Enzymes Are Proficient Catalysts: Beyond the Pauling Paradigm
inferredcites →https://doi.org/10.1021/bi00013a008openalex-snapshot
Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme
inferredcites →https://doi.org/10.1021/ci034189kopenalex-snapshot
CoMFA Modeling of Human Catechol O-Methyltransferase Enzyme Kinetics
inferredcites →https://doi.org/10.1021/ct800445xopenalex-snapshot
Computations of Absolute Solvation Free Energies of Small Molecules Using Explicit and Implicit Solvent Model
inferredcites →https://doi.org/10.1021/ct900587bopenalex-snapshot
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
inferredcites →https://doi.org/10.1021/ja0299497openalex-snapshot
Theoretical Modeling of Enzyme Catalytic Power: Analysis of “Cratic” and Electrostatic Factors in Catechol O -Methyltransferase
inferredcites →https://doi.org/10.1021/ja051503dopenalex-snapshot
On the Nature of the Transition State in Catechol O-Methyltransferase. A Complementary Study Based on Molecular Dynamics and Potential Energy Surface Explorations
inferredcites →https://doi.org/10.1021/ja971019dopenalex-snapshot
A Theoretical Examination of the Factors Controlling the Catalytic Efficiency of a Transmethylation Enzyme: Catechol O-Methyltransferase
inferredcites →https://doi.org/10.1021/ja9827447openalex-snapshot
Importance of Correlated Motions in Forming Highly Reactive Near Attack Conformations in Catechol O-Methyltransferase
inferredcites →https://doi.org/10.1021/ja992218vopenalex-snapshot
QM−FE and Molecular Dynamics Calculations on Catechol O-Methyltransferase: Free Energy of Activation in the Enzyme and in Aqueous Solution and Regioselectivity of the Enzyme-Catalyzed Reaction
inferredcites →https://doi.org/10.1021/jm0100279openalex-snapshot
Are Free Energy Calculations Useful in Practice? A Comparison with Rapid Scoring Functions for the p38 MAP Kinase Protein System
inferredcites →https://doi.org/10.1021/jm040848oopenalex-snapshot
Synthesis, Biological Evaluation, and Molecular Modeling Studies of a Novel, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferredcites →https://doi.org/10.1021/jm050362nopenalex-snapshot
A Critical Assessment of Docking Programs and Scoring Functions
inferredcites →https://doi.org/10.1021/jm0505720openalex-snapshot
A Multistep Approach to Structure-Based Drug Design: Studying Ligand Binding at the Human Neutrophil Elastase
inferredcites →https://doi.org/10.1021/jm061277yopenalex-snapshot
Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance
inferredcites →https://doi.org/10.1021/jm1001524openalex-snapshot
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferredcites →https://doi.org/10.1021/jm800498eopenalex-snapshot
Beyond Picomolar Affinities: Quantitative Aspects of Noncovalent and Covalent Binding of Drugs to Proteins
inferredcites →https://doi.org/10.1038/33653openalex-snapshot
Surface topography dependence of biomolecular hydrophobic hydration
inferredcites →https://doi.org/10.1038/368354a0openalex-snapshot
Crystal structure of catechol O-methyltransferase
inferredcites →https://doi.org/10.1063/1.1740193openalex-snapshot
Statistical Mechanical Theory of Transport Processes. VII. The Coefficient of Thermal Conductivity of Monatomic Liquids
inferredcites →https://doi.org/10.1063/1.1740409openalex-snapshot
High-Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases
inferredcites →https://doi.org/10.1063/1.1999637openalex-snapshot
Direct calculation of the binding free energies of FKBP ligands
inferredcites →https://doi.org/10.1063/1.2221680openalex-snapshot
Parallelized-over-parts computation of absolute binding free energy with docking and molecular dynamics
inferredcites →https://doi.org/10.1063/1.2221683openalex-snapshot
On the use of orientational restraints and symmetry corrections in alchemical free energy calculations
inferredcites →https://doi.org/10.1063/1.449208openalex-snapshot
Monte Carlo simulation of differences in free energies of hydration
inferredcites →https://doi.org/10.1063/1.456651openalex-snapshot
Treatment of rotational isomers in free energy evaluations. Analysis of the evaluation of free energy differences by molecular dynamics simulations of systems with rotational isomeric states
inferredcites →https://doi.org/10.1063/1.470117openalex-snapshot
A smooth particle mesh Ewald method
inferredcites →https://doi.org/10.1073/pnas.0407404102openalex-snapshot
Free energies of ligand binding for structurally diverse compounds
inferredcites →https://doi.org/10.1073/pnas.96.18.9997openalex-snapshot
The maximal affinity of ligands
inferredcites →https://doi.org/10.1103/physrevlett.91.140601openalex-snapshot
Equilibrium Free Energies from Nonequilibrium Measurements Using Maximum-Likelihood Methods
inferredcites →https://doi.org/10.1111/j.1527-3458.2007.00020.xopenalex-snapshot
Catechol‐ O ‐methyltransferase and Its Inhibitors in Parkinson's Disease
inferredcites →https://doi.org/10.1111/j.1600-0773.1990.tb00756.xopenalex-snapshot
Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease
inferredcites →https://doi.org/10.1124/mol.106.023119openalex-snapshot
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation
inferredcites →https://doi.org/10.1124/mol.62.4.795openalex-snapshot
Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application
inferredcites →https://doi.org/10.1145/1188455.1188544openalex-snapshot
Molecular dynamics---Scalable algorithms for molecular dynamics simulations on commodity clusters
inferredcites →https://doi.org/10.1146/annurev.bb.18.060189.002243openalex-snapshot
Free Energy Via Molecular Simulation: Applications to Chemical and Biomolecular Systems
inferredcites →https://doi.org/10.1146/annurev.pharmtox.39.1.19openalex-snapshot
METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-Methyltransferase
inferredcites →https://doi.org/10.1201/9781420007282openalex-snapshot
Comprehensive Handbook of Chemical Bond Energies
inferredcites →https://doi.org/10.1529/biophysj.106.084301openalex-snapshot
Absolute Binding Free Energy Calculations Using Molecular Dynamics Simulations with Restraining Potentials

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9783527808694.ch11openalex-snapshot
Opicapone, a Novel Catechol‐O‐Methyltranferase Inhibitor ( COMT ) to Manage the Symptoms of P arkinson's Disease
inferred← citeshttps://doi.org/10.1002/cpdd.188openalex-snapshot
Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study
inferred← citeshttps://doi.org/10.1002/cpdd.213openalex-snapshot
Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched white subjects
inferred← citeshttps://doi.org/10.1002/cpdd.217openalex-snapshot
Effect of 3 Single‐Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol‐O‐Methyltransferase Activity and Motor Response in Patients With Parkinson Disease
inferred← citeshttps://doi.org/10.1002/wcms.1455openalex-snapshot
Ligand binding free energy and kinetics calculation in 2020
inferred← citeshttps://doi.org/10.1007/978-3-030-62059-2_230openalex-snapshot
Entacapone/Tolcapone/Opicapone for Treating Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-56015-1_230-1openalex-snapshot
Entacapone/Tolcapone/Opicapone for Treating Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s00228-013-1602-9openalex-snapshot
Effect of moderate liver impairment on the pharmacokinetics of opicapone
inferred← citeshttps://doi.org/10.1007/s00228-014-1701-2openalex-snapshot
Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations
inferred← citeshttps://doi.org/10.1007/s00702-023-02623-8openalex-snapshot
Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations
inferred← citeshttps://doi.org/10.1007/s10822-013-9678-yopenalex-snapshot
Lead optimization mapper: automating free energy calculations for lead optimization
inferred← citeshttps://doi.org/10.1007/s10822-018-0153-7openalex-snapshot
Detailed potential of mean force studies on host–guest systems from the SAMPL6 challenge
inferred← citeshttps://doi.org/10.1007/s15202-018-1912-yopenalex-snapshot
Was leistet der neue COMT-Hemmer Opicapon?
inferred← citeshttps://doi.org/10.1007/s40120-021-00314-8openalex-snapshot
Pharmacokinetics, Pharmacodynamics, and Tolerability of Opicapone in Healthy Chinese and Caucasian Subjects: An Open-Label, Single-Center, Phase 1 Study
inferred← citeshttps://doi.org/10.1007/s40262-012-0024-7openalex-snapshot
Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects
inferred← citeshttps://doi.org/10.1007/s40265-014-0343-0openalex-snapshot
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00011-6openalex-snapshot
Kinetics of Drug-Target Binding: A Guide for Drug Discovery
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2013.10.014openalex-snapshot
Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2017.07.019openalex-snapshot
A single- and multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of opicapone, a novel COMT inhibitor, in rat
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2018.10.001openalex-snapshot
Inhibition of catechol-O-methyltransferase in the cynomolgus monkey by opicapone after acute and repeated administration
inferred← citeshttps://doi.org/10.1016/j.taap.2017.03.013openalex-snapshot
Pharmacokinetics of opicapone, a third-generation COMT inhibitor, after single and multiple oral administration: A comparative study in the rat
inferred← citeshttps://doi.org/10.1016/s1474-4422(15)00336-1openalex-snapshot
Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00105openalex-snapshot
Using AMBER18 for Relative Free Energy Calculations
inferred← citeshttps://doi.org/10.1021/acs.jctc.1c01271openalex-snapshot
Drug Discovery by Automated Adaptation of Chemical Structure and Identity
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01786openalex-snapshot
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00681openalex-snapshot
Free Energy Methods in Drug Design: Prospects of “Alchemical Perturbation” in Medicinal Chemistry
inferred← citeshttps://doi.org/10.1021/ct300796gopenalex-snapshot
Alchemical FEP Calculations of Ligand Conformer Focusing in Explicit Solvent
inferred← citeshttps://doi.org/10.1021/ct500161fopenalex-snapshot
Practical Aspects of Free-Energy Calculations: A Review
inferred← citeshttps://doi.org/10.1021/jm500572bopenalex-snapshot
Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
inferred← citeshttps://doi.org/10.1039/9781849737357-00083openalex-snapshot
Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones
inferred← citeshttps://doi.org/10.1063/1.4769292openalex-snapshot
Perspective: Alchemical free energy calculations for drug discovery
inferred← citeshttps://doi.org/10.1063/1.4792251openalex-snapshot
Separated topologies—A method for relative binding free energy calculations using orientational restraints
inferred← citeshttps://doi.org/10.1080/07391102.2019.1699446openalex-snapshot
Identification of novel flavonoid inhibitor of Catechol-O-Methyltransferase enzyme by molecular screening, quantum mechanics/molecular mechanics and molecular dynamics simulations
inferred← citeshttps://doi.org/10.1080/14656566.2017.1294683openalex-snapshot
Opicapone for the treatment of Parkinson’s disease
inferred← citeshttps://doi.org/10.1080/14737175.2017.1336086openalex-snapshot
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson’s disease treated with L-DOPA
inferred← citeshttps://doi.org/10.1080/14737175.2021.1968298openalex-snapshot
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone
inferred← citeshttps://doi.org/10.1080/17425255.2018.1430138openalex-snapshot
Pharmacokinetic drug evaluation of opicapone for the treatment of Parkinson’s disease
inferred← citeshttps://doi.org/10.1080/17460441.2020.1691165openalex-snapshot
Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson’s disease therapeutics
inferred← citeshttps://doi.org/10.1097/wnf.0000000000000538openalex-snapshot
Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
inferred← citeshttps://doi.org/10.1097/wnf.0000000000000679openalex-snapshot
Opicapone Improves the Pharmacokinetics of Levodopa Administered as Extended-Release Capsules
inferred← citeshttps://doi.org/10.1111/bcp.12081openalex-snapshot
Opicapone: a short lived and very long acting novel catechol‐ O ‐methyltransferase inhibitor following multiple dose administration in healthy subjects
inferred← citeshttps://doi.org/10.1111/bcp.12169openalex-snapshot
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
inferred← citeshttps://doi.org/10.1111/bcp.13156openalex-snapshot
Effect of opicapone multiple‐dose regimens on levodopa pharmacokinetics
inferred← citeshttps://doi.org/10.1111/bcp.15383openalex-snapshot
Absorption, metabolism and excretion of opicapone in human healthy volunteers
inferred← citeshttps://doi.org/10.1111/bph.13020openalex-snapshot
Pharmacological profile of opicapone, a third‐generation nitrocatechol catechol‐ O ‐methyl transferase inhibitor, in the rat
inferred← citeshttps://doi.org/10.1111/ene.12666openalex-snapshot
Effect of opicapone on levodopa pharmacokinetics, catechol‐O‐methyltransferase activity and motor fluctuations in patients with Parkinson's disease
inferred← citeshttps://doi.org/10.1177/1060028020974560openalex-snapshot
Opicapone (Ongentys): A New COMT Inhibitor for the Treatment of Parkinson’s Disease
inferred← citeshttps://doi.org/10.2147/dddt.s104227openalex-snapshot
Spotlight on opicapone as an adjunct to levodopa in Parkinson’s disease: design, development and potential place in therapy
inferred← citeshttps://doi.org/10.2147/dnnd.s256722openalex-snapshot
Clinical Utility of Opicapone in the Management of Parkinson’s Disease: A Short Review on Emerging Data and Place in Therapy
inferred← citeshttps://doi.org/10.2147/ndt.s279362openalex-snapshot
Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease
inferred← citeshttps://doi.org/10.2217/nmt-2016-0022openalex-snapshot
Clinical Pharmacology Review of Opicapone for the Treatment of Parkinson’s Disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.